RET and neoplasm: Taken together, our data confirmed that vitamin C can induce ROS production and depletion of antioxidant defenses in PTC cells harboring BRAFV600 mutation but not in cells characterized by RET/PTC rearrangements, reinforcing the idea that this compound exerts a selective effect in tumor cells with specific mutations.